HL7.FHIR.UV.SHC-VACCINATION\Vaccine: CVX

SMART Health Cards: Vaccination & Testing Implementation Guide, published by HL7 International - Public Health Work Group. This is not an authorized publication; it is the continuous build for version 0.6.2). This version is based on the current content of https://github.com/HL7/fhir-shc-vaccination-ig/ and changes regularly. See the Directory of published versions

ValueSet: Vaccine: CVX

Official URL: http://hl7.org/fhir/uv/shc-vaccination/ValueSet/vaccine-cvx				Version: 0.6.2
Active as of 2022-06-27				Computable Name: VaccineCVX

This value set includes all CVX codes, which identify vaccine products.

References

Logical Definition (CLD)

Include all codes defined in http://hl7.org/fhir/sid/cvx

Expansion

This value set contains 214 concepts

Expansion based on http://hl7.org/fhir/sid/cvx version 20210406

All codes in this table are from the system http://hl7.org/fhir/sid/cvx

Code	Display
54	adenovirus vaccine, type 4, live, oral
55	adenovirus vaccine, type 7, live, oral
82	adenovirus vaccine, unspecified formulation
24	anthrax vaccine
19	Bacillus Calmette-Guerin vaccine
27	botulinum antitoxin
26	cholera vaccine, unspecified formulation
29	cytomegalovirus immune globulin, intravenous
56	dengue fever vaccine
12	diphtheria antitoxin
28	diphtheria and tetanus toxoids, adsorbed for pediatric use
20	diphtheria, tetanus toxoids and acellular pertussis vaccine
106	diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
107	diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
110	DTaP-hepatitis B and poliovirus vaccine
50	DTaP-Haemophilus influenzae type b conjugate vaccine
120	diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
130	Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
01	diphtheria, tetanus toxoids and pertussis vaccine
22	DTP-Haemophilus influenzae type b conjugate vaccine
102	DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
57	hantavirus vaccine
52	hepatitis A vaccine, adult dosage
83	hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
84	hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
31	hepatitis A vaccine, pediatric dosage, unspecified formulation
85	hepatitis A vaccine, unspecified formulation
104	hepatitis A and hepatitis B vaccine
30	hepatitis B immune globulin
08	hepatitis B vaccine, pediatric or pediatric/adolescent dosage
42	hepatitis B vaccine, adolescent/high risk infant dosage
43	hepatitis B vaccine, adult dosage
44	hepatitis B vaccine, dialysis patient dosage
45	hepatitis B vaccine, unspecified formulation
58	hepatitis C vaccine
59	hepatitis E vaccine
60	herpes simplex virus, type 2 vaccine
46	Haemophilus influenzae type b vaccine, PRP-D conjugate
47	Haemophilus influenzae type b vaccine, HbOC conjugate
48	Haemophilus influenzae type b vaccine, PRP-T conjugate
49	Haemophilus influenzae type b vaccine, PRP-OMP conjugate
17	Haemophilus influenzae type b vaccine, conjugate unspecified formulation
51	Haemophilus influenzae type b conjugate and Hepatitis B vaccine
61	human immunodeficiency virus vaccine
118	human papilloma virus vaccine, bivalent
62	human papilloma virus vaccine, quadrivalent
86	immune globulin, intramuscular
87	immune globulin, intravenous
14	immune globulin, unspecified formulation
111	influenza virus vaccine, live, attenuated, for intranasal use
15	influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
16	influenza virus vaccine, whole virus
88	influenza virus vaccine, unspecified formulation
123	influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
10	poliovirus vaccine, inactivated
02	trivalent poliovirus vaccine, live, oral
89	poliovirus vaccine, unspecified formulation
39	Japanese Encephalitis Vaccine SC
63	Junin virus vaccine
64	leishmaniasis vaccine
65	leprosy vaccine
66	Lyme disease vaccine
03	measles, mumps and rubella virus vaccine
04	measles and rubella virus vaccine
94	measles, mumps, rubella, and varicella virus vaccine
67	malaria vaccine
05	measles virus vaccine
68	melanoma vaccine
32	meningococcal polysaccharide vaccine (MPSV4)
103	meningococcal C conjugate vaccine
114	meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
108	meningococcal ACWY vaccine, unspecified formulation
07	mumps virus vaccine
69	parainfluenza-3 virus vaccine
11	pertussis vaccine
23	plague vaccine
33	pneumococcal polysaccharide vaccine, 23 valent
100	pneumococcal conjugate vaccine, 7 valent
109	pneumococcal vaccine, unspecified formulation
70	Q fever vaccine
18	rabies vaccine, for intramuscular injection RETIRED CODE
40	rabies vaccine, for intradermal injection
90	rabies vaccine, unspecified formulation
72	rheumatic fever vaccine
73	Rift Valley fever vaccine
34	rabies immune globulin
119	rotavirus, live, monovalent vaccine
122	rotavirus vaccine, unspecified formulation
116	rotavirus, live, pentavalent vaccine
74	rotavirus, live, tetravalent vaccine
71	respiratory syncytial virus immune globulin, intravenous
93	respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
06	rubella virus vaccine
38	rubella and mumps virus vaccine
76	Staphylococcus bacteriophage lysate
113	tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
09	tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
115	tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
35	tetanus toxoid, adsorbed
112	tetanus toxoid, unspecified formulation
77	tick-borne encephalitis vaccine
13	tetanus immune globulin
95	tuberculin skin test; old tuberculin, multipuncture device
96	tuberculin skin test; purified protein derivative solution, intradermal
97	tuberculin skin test; purified protein derivative, multipuncture device
98	tuberculin skin test; unspecified formulation
78	tularemia vaccine
91	typhoid vaccine, unspecified formulation
25	typhoid vaccine, live, oral
41	typhoid vaccine, parenteral, other than acetone-killed, dried
53	typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
101	typhoid Vi capsular polysaccharide vaccine
75	vaccinia (smallpox) vaccine
105	vaccinia (smallpox) vaccine, diluted
79	vaccinia immune globulin
21	varicella virus vaccine
81	Venezuelan equine encephalitis, inactivated
80	Venezuelan equine encephalitis, live, attenuated
92	Venezuelan equine encephalitis vaccine, unspecified formulation
36	varicella zoster immune globulin
117	varicella zoster immune globulin (Investigational New Drug)
37	yellow fever vaccine
121	zoster vaccine, live
998	no vaccine administered
999	unknown vaccine or immune globulin
99	RESERVED - do not use
133	pneumococcal conjugate vaccine, 13 valent
134	Japanese Encephalitis vaccine for intramuscular administration
137	HPV, unspecified formulation
136	meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
135	influenza, high dose seasonal, preservative-free
131	Historical record of a typhus vaccination
132	Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
128	Novel influenza-H1N1-09, all formulations
125	Novel Influenza-H1N1-09, live virus for nasal administration
126	Novel influenza-H1N1-09, preservative-free, injectable
127	Novel influenza-H1N1-09, injectable
138	tetanus and diphtheria toxoids, not adsorbed, for adult use
139	Td(adult) unspecified formulation
140	Influenza, seasonal, injectable, preservative free
129	Japanese Encephalitis vaccine, unspecified formulation
141	Influenza, seasonal, injectable
142	tetanus toxoid, not adsorbed
143	Adenovirus, type 4 and type 7, live, oral
144	seasonal influenza, intradermal, preservative free
145	respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
146	Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
147	Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
148	Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
149	influenza, live, intranasal, quadrivalent
150	Influenza, injectable, quadrivalent, preservative free
151	influenza nasal, unspecified formulation
152	Pneumococcal Conjugate, unspecified formulation
153	Influenza, injectable, Madin Darby Canine Kidney, preservative free
154	Hepatitis A immune globulin
155	Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free
156	Rho(D) Immune globulin- IV or IM
157	Rho(D) Immune globulin - IM
158	influenza, injectable, quadrivalent, contains preservative
159	Rho(D) Unspecified formulation
160	Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
801	AS03 Adjuvant
161	Influenza, injectable,quadrivalent, preservative free, pediatric
162	meningococcal B vaccine, fully recombinant
163	meningococcal B vaccine, recombinant, OMV, adjuvanted
164	meningococcal B, unspecified formulation
165	Human Papillomavirus 9-valent vaccine
166	influenza, intradermal, quadrivalent, preservative free, injectable
167	meningococcal vaccine of unknown formulation and unknown serogroups
168	Seasonal trivalent influenza vaccine, adjuvanted, preservative free
169	Hep A, live attenuated-IM
170	non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
171	Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent
172	cholera, WC-rBS
173	cholera, BivWC
174	cholera, live attenuated
175	Human Rabies vaccine from human diploid cell culture
176	Human rabies vaccine from Chicken fibroblast culture
177	pneumococcal conjugate vaccine, 10 valent
178	Non-US bivalent oral polio vaccine (types 1 and 3)
179	Non-US monovalent oral polio vaccine, unspecified formulation
180	tetanus immune globulin
181	anthrax immune globulin
182	Oral Polio Vaccine, Unspecified formulation
183	Yellow fever vaccine alternative formulation
184	Yellow fever vaccine, unspecified formulation
185	Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free
186	Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative
187	zoster vaccine recombinant
188	zoster vaccine, unspecified formulation
189	Hepatitis B vaccine (recombinant), CpG adjuvanted
190	Typhoid conjugate vaccine (non-US)
191	meningococcal A polysaccharide vaccine (non-US)
192	meningococcal AC polysaccharide vaccine (non-US)
193	hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
194	influenza, Southern Hemisphere, unspecified formulation
195	Diphtheria, Tetanus, Poliomyelitis adsorbed
196	tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
197	influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free
200	influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
201	influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative
202	influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
198	Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
203	meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free
205	influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free
206	smallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile)
207	SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose
208	SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
213	SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
210	SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
212	SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 ml
204	Ebola Zaire vaccine, live, recombinant, 1mL dose
214	Ebola, unspecified
211	SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

System

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code